m6Am修饰酶PCIF1调控靶基因ACOT8参与胃癌进展的机制研究

彭进, 王伟宁, 谭智, 叶冠男, 周震

  1. 长沙市第一医院消化内科，湖南 长沙 410000
  • 收稿日期:2022-04-03 修回日期:2023-03-07 出版日期:2023-04-30 发布日期:2023-05-15
  • 通信作者: 王伟宁
  • 作者简介:彭进（ORCID：0009-0005-4434-7561），硕士，主治医师。
  • 基金资助:
    湖南省卫生健康委科研计划课题(B2019134)

PDF

摘要/Abstract

摘要：

背景与目的：最新证据显示N6, 2'-O- 二甲基腺苷（N6, 2'-O-dimethyladenosine，m6Am）修饰酶磷酸化C末端结构域相互作用因子1（phosphorylated c-terminal domain-interacting factor 1，PCIF1）可能是胃癌的重要生物标志物及治疗靶点。然而，这种新的PCIF1分子机制与胃癌进展的关系仍有待进一步探索。本研究分析PCIF1对胃癌细胞增殖、迁移和侵袭的调控作用及其调控靶基因酰基辅酶A硫代酯酶8（acyl-CoA thioesterase 8，ACOT8）在胃癌进展中的机制。方法：使用基因表达谱交互分析（gene expression profiling interactive analysis，GEPIA）分析胃癌患者的胃癌组织和非胃癌组织中的PCIF1表达，并分析了PCIF1表达与胃癌患者总生存率的相关性。收集2019年——2021年长沙市第一医院消化内科就诊患者的89对胃癌组织和匹配的癌旁组织。通过实时荧光定量聚合酶链反应（real-time fluorescence quantitative polymerase chain reaction，RTFQ-PCR）和蛋白质印迹法（Western blot）分析PCIF1表达。在体外实验中，将SNU5细胞分为PCIF1敲低（sh-PCIF1）组和相应对照（sh-NC）组，将AGS细胞分为载体对照组（normal control，NC）组和PCIF1过表达（PCIF1）组。使用细胞计数试剂盒-8（cell counting kit-8，CCK-8）、5-乙炔基-2'-脱氧尿苷（5-ethynyl-2'-deoxyuridine，EdU）和transwell法分析了PCIF1对胃癌细胞增殖、侵袭和迁移的影响。此外，在PCIF1过表达的AGS细胞中敲低ACOT8并进行了拯救实验。采用皮下异种移植瘤模型来测定PCIF1在胃癌中的生物学效应。结果：PCIF1在胃癌组织和细胞系中呈高表达，并且PCIF1高表达胃癌患者的预后较差。与sh-NC组相比，sh-PCIF1组的细胞活力、EdU阳性细胞、迁移和侵袭细胞数均显著降低（P<0.05）。与NC组相比，PCIF1组的细胞活力、EdU阳性细胞、迁移和侵袭细胞数均显著增加（P<0.05）。在PCIF1过表达的AGS细胞中，敲低ACOT8的表达可降低细胞活力、EdU阳性细胞、迁移和侵袭细胞数。在体内实验中，与NC组相比，PCIF1过表达组裸鼠的移植瘤体积和重量均显著增加（P<0.05）。结论：PCIF1在胃癌细胞系和组织中上调。此外，PCIF1/ACOT8轴参与介导胃癌细胞的恶性行为产生。

关键词: N6, 2'-O-二甲基腺苷, 磷酸化C末端结构域相互作用因子1, 酰基辅酶A硫代酯酶8, 胃癌, 增殖, 转移

Abstract:

Background and purpose: Recent evidence suggests that N6, 2'-O- dimethyladenosine (m6Am) modifying enzyme phosphorylated C-terminal domain-interacting factor 1 (PCIF1) may be an important biomarker/therapeutic target in gastric cancer. However, the relationship between this novel PCIF1 molecular mechanism and gastric cancer progression remains to be further explored. In this study, we analyzed the regulatory role of PCIF1 on gastric cancer proliferation, migration and invasion and the mechanism of its regulatory target gene ACOT8 in gastric cancer progression. Methods: PCIF1 expression in gastric cancer and non-gastric cancer tissues of gastric cancer patients was analyzed using Gene Expression Profile Interaction Analysis (GEPIA), and the correlation of PCIF1 expression with overall survival in gastric cancer patients was analyzed. We collected all gastric cancer tissues and matched para-cancerous tissues from 89 primary gastric cancer patients treated in Department of Gastroenterology of Changsha First Hospital from 2019 to 2021. PCIF1 expression was analyzed by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) and Western blot. In in vitro experiments, SNU5 cells were divided into PCIF1 knockdown (sh-PCIF1) group and corresponding control (sh-NC) group, and AGS cells were divided into vehicle as normal control (NC) group and PCIF1 overexpression (PCIF1) group. The effect of PCIF1 on gastric cancer cell proliferation, invasion and migration was investigated using cell counting kit-8 (CCK-8), EdU and transwell assays. Furthermore, ACOT8 expression was knocked down in PCIF1-overexpressing AGS cells, and rescue experiments were performed. A subcutaneous xenograft model was used to determine the biological effects of PCIF1 in gastric cancer in vivo. Results: PCIF1 expression was abnormally high in gastric cancer tissues and cell lines, with significant correlation between PCIF1 expression and the prognosis of gastric cancer patients. Compared with the sh-NC group, the cell viability, EdU positive cells, migration and invasion cell numbers in the sh-PCIF1 group were significantly decreased (P<0.05). Compared with the NC group, the cell viability, EdU positive cells, migration and invasion cell numbers in the PCIF1 group were significantly increased (P<0.05). In PCIF1-overexpressing AGS cells, knockdown of ACOT8 expression decreased cell viability, EdU-positive cells and migrating and invasive cell numbers. In vivo experiments showed, compared with the NC group, the tumor volume and weight of the nude mice in the PCIF1-overexpressing group were significantly increased (P<0.05). Conclusions: PCIF1 is upregulated in gastric cancer cell lines and tissues. In addition, the PCIF1/ACOT8 axis is involved in mediating the malignant behavior of gastric cancer cells.

Key words: N6, 2′-O-dimethyladenosine, Phosphorylated C-terminal domain-interacting factor 1, Acyl-CoA thioesterase 8, Gastric cancer, Proliferation, Metastasis

中图分类号: 

相关文章

[1] 蒋金玲, 周尘飞, 王超, 赵丽琴, 吴珺玮, 张俊. 2022年度胃癌研究和诊疗新进展[J]. 中国癌症杂志, 2023, 33(4): 303-314.
[2] 肖岚姝, 潘柳荻, 刘毅, 王洁, 陈惠. LncRNA DLEU7-AS1通过调控膜突蛋白MSN的表达促进胃癌细胞增殖与迁移的作用机制[J]. 中国癌症杂志, 2023, 33(4): 327-341.
[3] 陈红, 陈俊霞. 环状RNA hsa_circ_0001573对乳腺癌细胞生物学行为的影响及机制研究[J]. 中国癌症杂志, 2023, 33(4): 342-353.
[4] 刘洋, 胡奕炀, 刘月平, 牛淑瑶, 丁平安, 田园, 郭洪海, 杨沛刚, 张泽, 郑涛, 檀碧波, 范立侨, 李勇, 赵群. 人工智能辅助技术在胃癌新辅助化疗患者HER2表达评估中的价值[J]. 中国癌症杂志, 2023, 33(4): 377-387.
[5] 符庆胜, 金雷, 张旭东, 徐荧晨, 朱春富, 秦锡虎, 吴宝强. tRF-Pro-CGG对小鼠胰腺癌细胞生物学行为的影响及其分子机制[J]. 中国癌症杂志, 2023, 33(3): 241-249.
[6] 赵满英, 伍东月, 杜瑞亭, 尹璐, 骆玉露. METTL14介导ERα的m6A修饰调控子宫内膜癌转移的机制研究[J]. 中国癌症杂志, 2023, 33(3): 250-259.
[7] 冷婕, 邱国春, 张菠, 蒲艳. 乳腺癌中心体调控蛋白SEC23B在肿瘤浸润转移中的作用及其机制研究[J]. 中国癌症杂志, 2023, 33(2): 152-161.
[8] 陈馨宁, 姜惠琴, 杨轶慧, 虞倩, 张春燕, 王蓓丽, 潘柏申, 郭玮. 血浆Septin9基因甲基化状态和水平在胃癌患者诊断和预后评估中的应用价值[J]. 中国癌症杂志, 2023, 33(2): 162-167.
[9] 王笑笑, 陈曦, 李敏敏, 宋宁, 孙冬瑗, 蒋英英. NOL8对口腔鳞状细胞癌细胞增殖、迁移及侵袭的影响[J]. 中国癌症杂志, 2023, 33(1): 45-53.
[10] 刘雪萍, 木乃, 李晓春, 王锐锶, 谭榜宪. 肝癌伴上下牙龈多发转移1例[J]. 中国癌症杂志, 2023, 33(1): 78-80.
[11] 禹航, 刘文生, 张宁, 刘海宽, 陈洛海, 姚望, 范文哲, 李家平, 陈洁, 王于. 肝动脉栓塞术治疗囊性神经内分泌肿瘤肝转移的疗效及安全性分析[J]. 中国癌症杂志, 2022, 32(9): 794-799.
[12] 郑秀丽, 姚志原, 吴明利, 尔丽绵, 李胜棉. 直肠神经内分泌肿瘤淋巴结转移的危险因素分析及内镜切除方式比较[J]. 中国癌症杂志, 2022, 32(9): 800-806.
[13] 张景臣, 李新, 李江涛, 李海平, 陈艳丽, 牛冰, 祁川川, 叶贝贝. LINC02163靶向miR-338-3p影响乳腺癌细胞增殖、侵袭及迁移[J]. 中国癌症杂志, 2022, 32(9): 818-826.
[14] 蔡钢, 王舒蓓, 陈佳艺. 放射治疗在胃癌全程管理中的现状与挑战[J]. 中国癌症杂志, 2022, 32(7): 581-587.
[15] 曹孟轩, 胡灿, 张延强, 黄灵, 杜义安, 于鹏程, 章若岚, 徐志远, 程向东. 胃癌根治术后早期复发转移的危险因素分析[J]. 中国癌症杂志, 2022, 32(7): 588-595.

地址：上海市东安路270号（复旦大学肿瘤医院内）　上海市抗癌协会办公室电话/传真：021-64042258

上海市通信管理局备案 　沪ICP备06014835号 　 版权所有: 上海市抗癌协会